Publications by authors named "Roger Dale"

Claim this Profile
A
A generalised method for calculating repopulation-corrected tumour EQD2 values in a wide range of clinical situations, including interrupted treatments.
Roger Dale, Georgios Plataniotis, Bleddyn Jones

Phys Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiobiological effectiveness difference of proton arc beams versus conventional proton and photon beams.
Alejandro Carabe, Ilias V Karagounis, Kiet Huynh, Alejandro Bertolet, Noelle François, Roger Dale

Phys Med Biol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia.
Nuradh Joseph, Norman F Kirkby, Peter J Hoskin, Catharine M L West, Ananya Choudhury, Roger G Dale

Br J Radiol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin αvβ6 Positron Emission Tomography Imaging in Lung Cancer Patients Treated With Pulmonary Radiation Therapy.
Azeem Saleem, Yusuf Helo, Zarni Win, Roger Dale, Jo Cook

Int J Radiat Oncol Biol Phys· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for arcing techniques in proton therapy?
Alejandro Carabe-Fernandez, Alejandro Bertolet-Reina, Ilias Karagounis, Kiet Huynh, Roger G Dale

Br J Radiol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial.
Atif J Khan, Peter Y Chen, Catheryn Yashar, Matthew M Poppe, Linna Li, Roger Dale

Int J Radiat Oncol Biol Phys· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation repair models for clinical application.
Roger G Dale

Br J Radiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Christy Goldsmith, P Nicholas Plowman, Melanie M Green, Roger G Dale, Patricia M Price

Radiat Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the radiation-equivalent of chemotherapy contributions in 1-phase radio-chemotherapy treatment of muscle-invasive bladder cancer.
George A Plataniotis, Roger G Dale

Int J Radiat Oncol Biol Phys· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator.
Alexandra J Stewart, Jaroslaw T Hepel, Desmond A O'Farrell, Phillip M Devlin, Lori Lyn Price, Roger G Dale

Radiother Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control.
George A Plataniotis, Roger G Dale

World J Radiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrashort courses of adjuvant breast radiotherapy: wave of the future or a fool's errand?
Atif J Khan, Roger G Dale, Douglas W Arthur, Bruce G Haffty, Dorin A Todor

Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-short courses of adjuvant breast radiotherapy: promised land or primrose path?
Atif J Khan, Douglas W Arthur, Roger G Dale, Bruce G Haffty, Frank A Vicini

Int J Radiat Oncol Biol Phys· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Is a "BED" not a "BED"?-When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304).
Jack F Fowler, Roger G Dale

Int J Radiat Oncol Biol Phys· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal dosimetry.
Barry W Wessels, Roger G Dale, Marta Cremonesi, Ruby F Meredith, Alan J Green

Cancer Biother Radiopharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
George A Plataniotis, Roger G Dale

Int J Radiat Oncol Biol Phys· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results.
George A Plataniotis, Roger G Dale

Int J Radiat Oncol Biol Phys· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charged particle therapy for cancer: the inheritance of the Cavendish scientists?
Bleddyn Jones, Roger G Dale, Alejandro Cárabe-Fernández

Appl Radiat Isot· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials.
George A Plataniotis, Roger G Dale

Int J Radiat Oncol Biol Phys· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Barry W Wessels, Mark W Konijnenberg, Roger G Dale, Hazel B Breitz, Marta Cremonesi

J Nucl Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
Bleddyn Jones, Roger G Dale

Int J Radiat Oncol Biol Phys· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiobiologic modeling of cytoprotection effects in radiotherapy.
George A Plataniotis, Roger G Dale

Int J Radiat Oncol Biol Phys· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments.
Alejandro Carabe-Fernandez, Roger G Dale, Bleddyn Jones

Int J Radiat Biol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linear quadratic modeling of increased late normal-tissue effects in special clinical situations.
Bleddyn Jones, Roger G Dale, Andrew M Gaya

Int J Radiat Oncol Biol Phys· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The radiobiology of conventional radiotherapy and its application to radionuclide therapy.
Roger Dale, Alejandro Carabe-Fernandez

Cancer Biother Radiopharm· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis